NEXENTIS TECHNOLOGIES INC. Operating Lease, Liability, Current
NEXENTIS TECHNOLOGIES INC. (NXTS) had Operating Lease, Liability, Current of $7.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-03-31
- 2025-12-31: Operating Lease, Liability, Current $7.00K.
- 2024-12-31: Operating Lease, Liability, Current $7.00K.
- 2023-12-31: Operating Lease, Liability, Current $41.00K; Operating Lease, Liability, Current as first filed $40.52K.
- 2022-12-31: Operating Lease, Liability, Current $66.31K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2025-12-31 | $7.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $7.00K 10-K · filed 2026-03-31 | |
| 2023-12-31 | $41.00K 10-K · filed 2025-03-31 | $40.52K 10-K · filed 2024-04-01 |
| 2022-12-31 | $66.31K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |